New 52 Week High Today

Sutro Biopharma Inc STRO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:29 PM EDT
5.65UNCH (UNCH)
Volume
19,018
Close
5.65quote price arrow up+0.72 (+14.60%)
Volume
3,114,216
52 week range
2.01 - 6.13
Loading...
  • Open4.97
  • Day High6.13
  • Day Low4.97
  • Prev Close4.93
  • 52 Week High6.13
  • 52 Week High Date03/28/24
  • 52 Week Low2.01
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap352.797M
  • Shares Out62.44M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change31.7

KEY STATS

  • Open4.97
  • Day High6.13
  • Day Low4.97
  • Prev Close4.93
  • 52 Week High6.13
  • 52 Week High Date03/28/24
  • 52 Week Low2.01
  • 52 Week Low Date11/13/23
  • Market Cap352.797M
  • Shares Out62.44M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change31.7

RATIOS/PROFITABILITY

  • EPS (TTM)-1.79
  • P/E (TTM)-3.15
  • Fwd P/E (NTM)-1.56
  • EBITDA (TTM)-82.462M
  • ROE (TTM)-58.25%
  • Revenue (TTM)153.731M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-69.47%
  • Debt To Equity (MRQ)2.71%

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sutro Biopharma Inc

 

Profile

MORE
Sutro Biopharma, Inc. is a clinical-stage oncology company. The Company is engaged in developing site-specific and novel-format antibody drug conjugates (ADCs) enabled by its integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. It provides two wholly owned ADCs in the clinic, namely luveltamab tazevibulin (STRO-002 or luvelta) and STRO-001. STRO-002 is an ADC directed against folate receptor-alpha (FolRa) for...
Connie Matsui
Independent Chairman of the Board
William Newell J.D.
Chief Executive Officer, Director
Jane Chung
President, Chief Operating Officer
Edward Albini
Chief Financial Officer
Address
111 Oyster Point Blvd.
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
AGEN
Agenus Inc
0.58+0.0236+4.2416%
FGEN
FibroGen Inc
2.35-0.23-8.91%
KPTI
Karyopharm Therapeutics Inc
1.51+0.03+2.03%
XERS
Xeris Biopharma Holdings Inc
2.21+0.17+8.33%
SGMO
Sangamo Therapeutics Inc
0.6702+0.0455+7.2835%